The licence agreement bolsters Kite’s expertise in synthetic biology for oncology
News
ICR’s new study tracks disease progression in children with rare type of cancer
Researchers assessed whether measuring DNA shed by cancer cells into the bloodstream could track tumour progression
Cancer diagnoses decrease across England during 2020
Statistics show an average of 789 new malignant cancers diagnosed per day in 2020
Gedeon Richter announces availability of oral contraception Drovelis
Option contains new, synthetic version of naturally occurring oestrogen
Apogenix’s asunercept demonstrates efficacy in COVID-19 trial
Therapy showed faster clinical recovery for combined treatment groups
Grifols’ Tavlesse receives NICE recommendation
Therapy treats refractory chronic immune thrombocytopenia and is available across UK
AlzeCure gets new Alzheimer’s abstract accepted
Therapy is based on ACD856’s indicative disease modifying effects against the condition
Kite’s Yescarta to receive European marketing authorisation
First treatment in 30 years to improve second-line treatment of DLBCL
Parliament square set for ME research demonstration
Demonstrators will demand hundreds of millions of pounds ‘missing’ from ME research
NHS Confederation responds to the appointment of Jeremy Hunt
New Chancellor of the Exchequer left in no doubt regarding challenges ahead
XBiotech enrols first patient in Natrunix study
Therapy involves patients with colorectal cancer at 20 medical centres
Patient recruitment completed in Tourette syndrome study
Research has demonstrated a strong safety prolife and reduced tics among participants
3.2m UK birds culled as record avian flu cases increase
Virus can be lethal to humans and its spread is likely to accelerate this winter
PharmaLex seals merger with UK’s NeoHealthHub
Agreement will be key to building a pan-European market access practice
Liverpool city region wins government status for vaccine discovery
DIT to showcase Liverpool city region’s life sciences expertise which will also include manufacturing
